Our investors include Creathor Venture, IBB Beteiligungsgesellschaft (VC Fond Berlin), LBBW Venture Capital, KfW (ERP Startfonds) as well as private investors including prominent business angels from the life sciences communities.
If you are a member of the investment community and would like to learn more about caprotec, contact us or register to receive headline stories every time a news release is issued.
About IBB Beteiligungsgesellschaft
IBB Beteiligungsgesellschaft (www.ibb-bet.de) provides venture capital to innovative Berlin-based companies and has established itself as a market leader in the field of early stage financing in Germany. The funds are used primarily for the development and market launch of innovative products or services, as well as for business concepts of creative industries. Currently two of the funds managed by the IBB Beteiligungsgesellschaft are in the investment phase, the VC Fonds Technologie Berlin II with a fund size of 60M € and the VC Fonds Kreativwirtschaft Berlin II with a fund size of 40M €. Both VC funds are financed by means of the Investitionsbank Berlin (IBB) and the European Fund for Regional Development (EFRE) administered by the State Berlin. Since 1997 the IBB Beteiligungsgesellschaft, in consortia with partners, has made 1.006M € available to creative and technology-orientated companies; thereof, the portion invested by IBB Beteiligungsgesellschaft itself, as lead, co-lead or co-investor, was approximately 141M €.
About Creathor Venture
Creathor Venture manages funds of more than €220 million and invests in technology-oriented companies and entrepreneurs in the areas of precision medicine, enabling platforms, medtech, digital health, mobile, digital media, cloud technology, artificial intelligence, internet of things, sharing economy and fintech.
The management team of Creathor Venture consists of the CEO Dr. Gert Köhler, Karlheinz Schmelig and Cédric Köhler. The team has been investing successfully in the early-stage venture capital business for 30 years. During that time, the team has built more than 200 technology companies successfully, conducted more than 20 international IPOs and has achieved exceptional returns for fund investors and the financed entrepreneurs in the past, all in the position as lead investor. Successful portfolio companies in the field of life sciences are amongst others Sividon Diagnostics, Accovion, SiRION Biotech, Caprotec Bioanalytics, Phenex Pharmaceuticals and CEVEC Pharmaceuticals.
About KfW Mittelstandsbank
KfW Mittelstandsbank brings together all KfW's offers for business start-ups and small and medium-sized enterprises, thus promoting commercial investments over the entire life cycle of an enterprise. The SME financing products are structured according to the three pillars of loan, mezzanine and equity capital. In addition to investment finance, KfW Mittelstandsbank provides relevant information and advice. In promoting investment by German companies in Germany and abroad, KfW Mittelstandsbank acts as a bank behind credit institutions and other financial intermediaries, working with them as partners. KfW Mittelstandsbank is continuously developing its promotional instruments and adjusting them to changes in the market.
About LBBW Venture Capital GmbH
LBBW Venture is a subsidiary of Landesbank Baden-Württemberg and invests in Life Science, IT and industrial technology in Germany since more than ten years. Portfolio companies in the Life Science sector are Cellzome, Curacyte Pharmaceuticals, Phenex Pharmaceuticals, mtm laboratories and several fund in fund investments. Most recently the portfolio companies ProbioGen and Sloning were successfully sold.
LBBW Venture Capital GmbH
Dr. Harald Poth
Tel.: +49 711 305 89 20 61
Fax: +49 711 305 89 20 99